Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,732,627
-$62,251,886 QoQ
Shares Held
4,325,689
-32.8% QoQ
Ownership
4.10%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#7
of 323 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. SRPT ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in SRPT
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,732,627 | 4,325,689 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $95,774,547 | 5,329,691 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $139,984,513 | 6,433,112 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $167,781,430 | 7,796,535 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $27,087,355 | 1,405,675 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,154,240 | 125,979 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $343,668 | 5,385 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $208,404 | 1,714 | Shares | Defined | 2025-02-14 | |
| 2023-09-30 | $1,020,914 | 8,422 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,113,248 | 9,721 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,087,754 | 7,892 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $366,193 | 2,826 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $301,884 | 2,731 | Shares | Defined | 2022-11-14 | |
| 2020-12-31 | $824,148 | 4,834 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $704,116 | 5,014 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $297,591 | 1,856 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $458,971 | 4,692 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||